News

July 3, 2020

2019 AJOG. M281, an anti-FcRn antibody, inhibits IgG transfer in ahuman ex vivo placental perfusion model.

2019 American Journal of obstetrics. AJOG. Important study regarding M281, a monoclonal anti-FcRn antibody. If the study eventually shows blocking of FcRn with Nipocalimab is a […]

June 5, 2020

June 1 2020. FNAIT progress update – FcRn blocker Nipocalimab – Dr James B Bussel MD, New York.

1 June 2020. FNAIT progess update from: James B Bussel, MD. Pediatric Hematology & Oncology New York, NY Dear Members of NAITBABIES and the community interested […]

May 20, 2020

Latest news from Rallybio. 19 May 2020. Rallybio announce their Lead Product Candidate RLYB211, a plasma-derived hyperimmune globulin in development for the prevention of FNAIT.

Rallybio have announced the following news regarding financing, development and it’s Lead Product Candidate, RLY211. RLYB211 is a plasma-derived hyperimmune globulin in development for the prevention […]

May 2, 2020

Due to the pandemic coronavirus – COVID-19 Naitbabies have postponed future exhibitions and conferences until further notice.

Due to the pandemic coronavirus – COVID-19 Naitbabies have postponed future exhibitions and conferences until further notice. We are working from home and our online Parents […]

February 11, 2020

11 February 2020. All set up for the first ever ”All Ireland” Maternity and Midwifery Festival, Dublin!!

We ‘re excited to be exhibiting at The first All Ireland Maternity and Midwifery Festival Croke Park, Dublin February 11 2020

May 25, 2019

READ THE LATEST EXCITING NEWS RELEASE ON THE DEVELOPMENT OF NAITgam!!!!!!

READ THE LATEST EXCITING NEWS NEWS RELEASE REGARDING THE DEVELOPMENT OF NAITgam!!!!!! Statement release from Soren Weis Dahl CEO, #Prophylix AS regarding the current status of […]